Has COVID-19 made us embrace the future?    UAE Team Emirates' Pogacar wins the Tour De France    UAE Announces 674 New COVID-19 Cases, 761 Recoveries, No Deaths in last 24 hours    Saudi International Team Discovers Evidence for Migrations to Arabian Peninsula Dating Back More Than 120,000 Years in Nafud Desert    Path ahead for Saudi Arabia post COVID is one of acceleration and transformation — Serco ME    Conditions set for merger of Umrah companies    Al-Nowair initiative launches environmental campaign    England to make breaking COVID-19 self-isolation illegal with fines up to £10,000    Italians vote in referendum on reducing parliament size    B20 and IEA call on the G20 to accelerate clean energy transitions for a resilient economic recovery    Ministry of Culture to set up Red Sea Museum at Bab Al-Bunt in Jeddah    KSrelief Distributes Shelter Materials to Displaced People in Marib, Yemen    KSrelief Distributes Shelter Tents to People Affected by Floods in Sudan    Bahrain Bourse Rises    Egypt Condemns Houthi Militia Targeting one of Border Villages in KSA    New expat body to help women, kids tackle pandemic trauma    All UN sanctions on Iran restored, says US    Al-Ahsa's Hassawi rice is ‘as precious as gold'    KSrelief donates tents, shelter to Sudan flood-hit    Iranian Kurdish political prisoner faces execution    Custodian of the Two Holy Mosques Congratulates President of Armenia on Independence Day    Saudi Press: Saudi Arabia Made Progress in its War Against Corruption    Weather Forecast for Sunday    ADNEC acquires ISNR Abu Dhabi    Every work has its fruits, so choose wisely    Pogacar poised to win Tour De France after historic time-trial ride UAE Team Emirates starlet set to become youngest Tour de France winner of the 21st century    Saudi Arabia Takes Part in UN Broadband Commission for Sustainable Development Meeting    UN, partners promote sport as a tool to prevent violent extremism    National Day festivities to include fashion show    S. Korea Urges ADB to Step Up Efforts for Transformation in Post-Pandemic Era    Wydad appeal over CAF 2019 Champions' final dismissed by CAS    ECZA Concludes Golden Sponsor Role for New World Model    Diabetes in Saudi Arabia: Prevalence, Prevention, and Progress    Zahraa, a Saudi graduate in media, follows her passion in car décor job    Saudi Youths Transfer Saudi Arabia's Culture via Animation Production    Saudi Scholarship Program to Promote Football Talents, abroad, Co-sign Accord with Spanish Real Sociedad    French Open to allow 11,500 fans per day between the three show courts    Saudi Films' Festival virtual Events Continued    Saudi Taekwondo Team Win 3-Medal, in Arab 1st virtually Held Championships    Saudi Films' Festival Events Continue, amid Wide-Scale Cultural Participation    Mediation center contributes to 22% decrease in divorces    Saudi Films' Festival Kicked off, in its 6th Edition    Saudi woman seeks to restrain wealthy hubby from remarrying    India's top minister Amit Shah tests positive for coronavirus    Eid Al-Adha Prayer Performed at the Grand Holy Mosque    Pilgrims Perform Dhuhr and Asr Prayers in Arafat Holy Site    Senior Scholars Council Issues Decision No. 246 Regarding Attendance of Friday Prayer and Prayers at Mosques in a Case of Spread of Epidemic or Fear of its Spread    Custodian of the Two Holy Mosques Addresses Citizens and Muslims on Eid Al-Fitr    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





UAE COVID-19 vaccine trial expands, with second center set up in Sharjah
Published in The Saudi Gazette on 06 - 08 - 2020

SHARJAH — The United Arab Emirates announced on Wednesday that its phase 3 clinical trials for a coronavirus vaccine are now open to volunteers outside of Abu Dhabi for the first time.
In a statement carried by state news agency WAM, the UAE's Ministry of Health and Prevention said it is now dedicating the Al Qarayen Health Center in Sharjah as the first center outside the Emirate of Abu Dhabi to register, screen and test volunteers wishing to participate in the world's first Phase III clinical trials of an inactivated vaccine to combat COVID-19.
The move has been taken in cooperation with the Abu Dhabi Department of Health, Abu Dhabi Health Services Company, SEHA, and G42 Healthcare.
Al Qarayen Health Center has the capacity to register and screen over 500 volunteers a day and is open to residents from Sharjah and neighboring emirates as the trials continue to gather nationwide momentum since the launch of #4Humanity campaign on July 16, 2020.
It is being managed by G42 Healthcare in partnership with the ministry and will play a central role in facilitating procedures for registering volunteers and conducting necessary tests.
Commenting on the development, Health Minister Abdul Rahman Bin Al Owais said: "The UAE health sector adopts a flexible and multi-track strategy in dealing with the COVID-19 pandemic, which depends on competent authorities conducting the largest possible number of medical tests and providing necessary care for the infected persons.''
''Meanwhile, we are strengthening our cooperation with international partners to support the development of a safe vaccine against the disease. Thus, expanding the geographical scope of the #4Humanity campaign to include all emirates aims to enhance the results of clinical trials and ensure the safety and effectiveness of the vaccine on a larger segment of individuals".
Al Owais added: "We are optimistic about achieving promising results that would support the global efforts being made to develop the vaccine. Allocating Al Qarayen Health Center as the first center outside of Abu Dhabi to register, screen and test volunteers is yet another a distinct contribution from the UAE, to be added to its impeccable record of achievements in the field of clinical
research thanks to the country's advanced infrastructure, the efficiency of its health system and ability to conduct medical research according to the highest international standards".
For his part, Dr. Mohammad Salim Al Olama, undersecretary at the ministry, stressed the ministry's keenness to harness all necessary resources and capabilities to ensure the full readiness of Al Qarayen Health Center and facilitate the success of the third phase of the tests.
"Thousands of people of different nationalities have already expressed their desire to take part in the clinical trials, which reflects the confidence in the UAE health system and its ability to conduct clinical trials to test the promising vaccine in partnership with local and international parties," Al Olama said.
CEO of G42 Healthcare, Ashish Koshy, said: "The #4Humanity program has captured the imagination of residents in every emirate who are keen to volunteer and help find a cure for the world's biggest health challenge of the 21st Century.
"Since the launch, it became quickly apparent of the strong desire of health authorities and residents across the UAE to play their part and help ensure the success of these trials at a truly national level. Our teams are now working closely with MOHAP and SEHA to ensure our advanced technology and measurement process complements their frontline testing of volunteers."
The extension of the trials process comes in the wake of the enormous success of a walk-in registration, screening and testing center that was opened by G42 Healthcare at ADNEC in Abu Dhabi prior to the Eid Al-Adha holidays that has already attracted thousands of volunteers and remains open from Sunday to Thursday from 8 a.m. to 8 p.m.
This continues to be a part of a series of national initiatives to foster population health and to enhance the UAE's medical research and development capabilities, including the local capacity to manufacture the vaccine.
The trial process is being conducted following the international guidelines stipulated by the World Health Organisation, WHO, and the Food and Drug Administration.
The phase III clinical trials follow the success of the phase I and phase II trials conducted by Sinopharm in China, which resulted in 100 percent of the volunteers generating antibodies after two doses in 28 days.
The phase III trials are open to individual volunteers aged between 18 and 60 living in the UAE and will last for three to six months, with the volunteers required to be available for follow-ups during this time.


Clic here to read the story from its source.